• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Multiparametric immune profiling in HPV- oral squamous cell cancer.人乳头瘤病毒相关口腔鳞状细胞癌的多参数免疫分析
JCI Insight. 2017 Jul 20;2(14). doi: 10.1172/jci.insight.93652.
2
Tumor Microenvironment, HLA Class I and APM Expression in HPV-Negative Oral Squamous Cell Carcinoma.人乳头瘤病毒阴性口腔鳞状细胞癌中的肿瘤微环境、HLA I类分子与抗原加工呈递分子表达
Cancers (Basel). 2021 Feb 4;13(4):620. doi: 10.3390/cancers13040620.
3
CD8+ and CD163+ infiltrating cells and PD-L1 immunoexpression in oral leukoplakia and oral carcinoma.口腔白斑和口腔癌中CD8 +和CD163 +浸润细胞及PD-L1免疫表达情况
APMIS. 2018 Sep;126(9):732-738. doi: 10.1111/apm.12881.
4
CD8+/FOXP3+ ratio and PD-L1 expression associated with survival in pT3N0M0 stage esophageal squamous cell cancer.CD8+/FOXP3+ 比值及程序性死亡受体配体1(PD-L1)表达与pT3N0M0期食管鳞状细胞癌的生存率相关。
Oncotarget. 2016 Nov 1;7(44):71455-71465. doi: 10.18632/oncotarget.12213.
5
Association Between PD-L1 and HPV Status and the Prognostic Value of PD-L1 in Oropharyngeal Squamous Cell Carcinoma.口咽鳞状细胞癌中PD-L1与HPV状态的关联及PD-L1的预后价值
Cancer Res Treat. 2016 Apr;48(2):527-36. doi: 10.4143/crt.2015.249. Epub 2015 Sep 15.
6
Prognostic value of tumor PD-L1 expression combined with CD8 tumor infiltrating lymphocytes in high grade serous ovarian cancer.肿瘤 PD-L1 表达联合 CD8 肿瘤浸润淋巴细胞对高级别浆液性卵巢癌的预后价值。
Int Immunopharmacol. 2017 Nov;52:7-14. doi: 10.1016/j.intimp.2017.08.017. Epub 2017 Aug 31.
7
Clinical and Biological Significance of PD-L1 Expression Within the Tumor Microenvironment of Oral Squamous Cell Carcinoma.口腔鳞状细胞癌肿瘤微环境中PD-L1表达的临床及生物学意义
Anticancer Res. 2019 Jun;39(6):3039-3046. doi: 10.21873/anticanres.13437.
8
Clinicopathologic implications of the miR-197/PD-L1 axis in oral squamous cell carcinoma.miR-197/PD-L1轴在口腔鳞状细胞癌中的临床病理意义
Oncotarget. 2017 Aug 3;8(39):66178-66194. doi: 10.18632/oncotarget.19842. eCollection 2017 Sep 12.
9
Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping.上皮内CD3+ T淋巴细胞增多以及肿瘤细胞上程序性死亡受体配体1(PD-L1)高表达与食管鳞状细胞癌的良好预后相关,并可进行预后免疫原性亚组划分。
Oncotarget. 2017 Jul 18;8(29):46756-46768. doi: 10.18632/oncotarget.18606.
10
Increased number of CD25 FoxP3 regulatory T cells in oral squamous cell carcinomas detected by chromogenic immunohistochemical double staining.通过显色免疫组织化学双重染色检测发现口腔鳞状细胞癌中CD25 FoxP3调节性T细胞数量增加。
J Oral Pathol Med. 2008 Sep;37(8):485-9. doi: 10.1111/j.1600-0714.2008.00641.x. Epub 2008 Mar 18.

引用本文的文献

1
GARP-expressing Tregs as a source of immunosuppressive TGF-β1 in human tumors.表达GARP的调节性T细胞作为人类肿瘤中免疫抑制性转化生长因子-β1的来源。
Cancer Immunol Immunother. 2025 Sep 13;74(10):308. doi: 10.1007/s00262-025-04157-2.
2
The regulatory role and mechanism of energy metabolism and immune response in head and neck cancer.能量代谢与免疫反应在头颈癌中的调控作用及机制
Genes Dis. 2025 Mar 19;12(6):101607. doi: 10.1016/j.gendis.2025.101607. eCollection 2025 Nov.
3
TME-analyzer: a new interactive and dynamic image analysis tool that identified immune cell distances as predictors for survival of triple negative breast cancer patients.TME分析器:一种新型交互式动态图像分析工具,该工具将免疫细胞距离确定为三阴性乳腺癌患者生存的预测指标。
Npj Imaging. 2024 Jul 25;2(1):21. doi: 10.1038/s44303-024-00022-6.
4
The responses of HNSCC patients to immunotherapy are shown by two novel co-expression patterns.头颈部鳞状细胞癌(HNSCC)患者对免疫疗法的反应通过两种新的共表达模式得以体现。
NPJ Precis Oncol. 2025 Jul 1;9(1):217. doi: 10.1038/s41698-025-00983-w.
5
The Spatial Proximity of CD8 FoxP3PD-1 Cells to Tumor Cells: A More Accurate Predictor of Immunotherapy Outcomes in Advanced Non-Small-Cell Lung Cancer.CD8 FoxP3PD-1细胞与肿瘤细胞的空间接近性:晚期非小细胞肺癌免疫治疗结果的更准确预测指标
Curr Oncol. 2025 Apr 30;32(5):262. doi: 10.3390/curroncol32050262.
6
HIV status alters immune cell infiltration and activation profile in women with breast cancer.人类免疫缺陷病毒(HIV)感染状况会改变乳腺癌女性患者的免疫细胞浸润及激活情况。
Nat Commun. 2025 May 20;16(1):4699. doi: 10.1038/s41467-025-59408-8.
7
Assessment of immune infiltrate in oral cancer: An immunohistochemical study.口腔癌中免疫浸润的评估:一项免疫组织化学研究。
J Oral Maxillofac Pathol. 2025 Jan-Mar;29(1):66-75. doi: 10.4103/jomfp.jomfp_184_24. Epub 2025 Mar 28.
8
Richness for Tumor-Infiltrating B-Cells in the Oral Cancer Tumor Microenvironment Is a Prognostic Factor in Early-Stage Disease and Improves Outcome in Advanced-Stage Disease.口腔癌肿瘤微环境中肿瘤浸润性B细胞的丰富度是早期疾病的一个预后因素,并可改善晚期疾病的预后。
Cancers (Basel). 2025 Jan 1;17(1):113. doi: 10.3390/cancers17010113.
9
Cancer cell-specific PD-L1 expression is a predictor of poor outcome in patients with locally advanced oral cavity squamous cell carcinoma.癌细胞特异性程序性死亡受体配体1(PD-L1)表达是局部晚期口腔鳞状细胞癌患者预后不良的一个预测指标。
J Immunother Cancer. 2024 Oct 2;12(10):e009617. doi: 10.1136/jitc-2024-009617.
10
Revolutionizing Pathology with Artificial Intelligence: Innovations in Immunohistochemistry.人工智能引领病理学变革:免疫组织化学的创新
J Pers Med. 2024 Jun 27;14(7):693. doi: 10.3390/jpm14070693.

本文引用的文献

1
Immunoprofiling as a predictor of patient's response to cancer therapy-promises and challenges.免疫组化分析作为预测患者对癌症治疗反应的指标:前景与挑战。
Curr Opin Immunol. 2017 Apr;45:60-72. doi: 10.1016/j.coi.2017.01.005. Epub 2017 Feb 20.
2
Overexpression and gene amplification of PD-L1 in cancer cells and PD-L1 immune cells in Epstein-Barr virus-associated gastric cancer: the prognostic implications.EB病毒相关胃癌中癌细胞和PD-L1免疫细胞中PD-L1的过表达和基因扩增:预后意义
Mod Pathol. 2017 Mar;30(3):427-439. doi: 10.1038/modpathol.2016.202. Epub 2016 Dec 9.
3
Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort.帕博利珠单抗在生物标志物未筛选的复发和/或转移性头颈部鳞状细胞癌患者中的抗肿瘤活性:Ib期KEYNOTE-012扩展队列研究结果
J Clin Oncol. 2016 Nov 10;34(32):3838-3845. doi: 10.1200/JCO.2016.68.1478. Epub 2016 Sep 30.
4
Aberrant PD-L1 expression through 3'-UTR disruption in multiple cancers.多种癌症中通过 3'-UTR 破坏导致的异常 PD-L1 表达。
Nature. 2016 Jun 16;534(7607):402-6. doi: 10.1038/nature18294. Epub 2016 May 23.
5
Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas.弥漫性大 B 细胞淋巴瘤中 PD-L1 过表达的遗传基础。
Blood. 2016 Jun 16;127(24):3026-34. doi: 10.1182/blood-2015-12-686550. Epub 2016 Mar 30.
6
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability.结直肠癌综合分析显示免疫评分是比微卫星不稳定性更强的患者生存预测指标。
Immunity. 2016 Mar 15;44(3):698-711. doi: 10.1016/j.immuni.2016.02.025.
7
CD44+ Cells in Head and Neck Squamous Cell Carcinoma Suppress T-Cell-Mediated Immunity by Selective Constitutive and Inducible Expression of PD-L1.头颈部鳞状细胞癌中的CD44+细胞通过PD-L1的选择性组成型和诱导型表达抑制T细胞介导的免疫。
Clin Cancer Res. 2016 Jul 15;22(14):3571-81. doi: 10.1158/1078-0432.CCR-15-2665. Epub 2016 Feb 10.
8
Novel technologies and emerging biomarkers for personalized cancer immunotherapy.用于个性化癌症免疫治疗的新技术和新兴生物标志物。
J Immunother Cancer. 2016 Jan 19;4:3. doi: 10.1186/s40425-016-0107-3. eCollection 2016.
9
High PD-L1 Expression Correlates with Metastasis and Poor Prognosis in Oral Squamous Cell Carcinoma.高程序性死亡受体配体1(PD-L1)表达与口腔鳞状细胞癌的转移及不良预后相关。
PLoS One. 2015 Nov 12;10(11):e0142656. doi: 10.1371/journal.pone.0142656. eCollection 2015.
10
Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma.福尔马林固定组织的多光谱成像可预测从黑色素瘤中产生肿瘤浸润淋巴细胞的能力。
J Immunother Cancer. 2015 Oct 20;3:47. doi: 10.1186/s40425-015-0091-z. eCollection 2015.

人乳头瘤病毒相关口腔鳞状细胞癌的多参数免疫分析

Multiparametric immune profiling in HPV- oral squamous cell cancer.

作者信息

Feng Zipei, Bethmann Daniel, Kappler Matthias, Ballesteros-Merino Carmen, Eckert Alexander, Bell R Bryan, Cheng Allen, Bui Tuan, Leidner Rom, Urba Walter J, Johnson Kent, Hoyt Clifford, Bifulco Carlo B, Bukur Juergen, Wickenhauser Claudia, Seliger Barbara, Fox Bernard A

机构信息

Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Portland, Oregon, USA.

Department of Cancer Biology, Oregon Health & Science University, Portland, Oregon, USA.

出版信息

JCI Insight. 2017 Jul 20;2(14). doi: 10.1172/jci.insight.93652.

DOI:10.1172/jci.insight.93652
PMID:28724788
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5518563/
Abstract

Evaluation of T lymphocyte frequency provides prognostic information for patients with oral squamous cell cancer (OSCC). However, the effect of simultaneously evaluating T cell frequency and assessing suppressive elements and defects in antigen-processing machinery (APM) has not been clarified. Simultaneous characterization of CD3+, CD8+, FoxP3+, CD163+, and PD-L1+ cells using multispectral imaging was performed on sections from 119 patients with HPV- OSCC. Expression of β2-microglobulin, MHC class I heavy chain, and large multifunctional peptidase 10 was quantified, and all data were correlated with patient outcome. We found that, consistent with previous reports, high numbers of CD8+ T cells at the invasive margin correlated significantly with prolonged overall survival (OS), while the number of FoxP3+ or PD-L1+ cells did not. Compiling the number of FoxP3+ or PD-L1+ cells within 30 μm of CD8+ T cells identified a significant association with a high number of suppressive elements close to CD8+ T cells and reduced OS. Integrating this information into a cumulative suppression index (CSI) increased correlation with OS. Incorporating tumor expression levels of APM components with CSI further improved prognostic power. This multiparametric immune profiling may be useful for stratifying patients with OSCC for clinical trials.

摘要

评估T淋巴细胞频率可为口腔鳞状细胞癌(OSCC)患者提供预后信息。然而,同时评估T细胞频率以及评估抑制性元件和抗原加工机制(APM)缺陷的效果尚未明确。使用多光谱成像对119例HPV阴性OSCC患者的切片进行CD3 +、CD8 +、FoxP3 +、CD163 +和PD-L1 +细胞的同时表征。对β2-微球蛋白、MHC I类重链和大型多功能肽酶10的表达进行定量,所有数据均与患者预后相关。我们发现,与先前报道一致,侵袭边缘大量的CD8 + T细胞与延长的总生存期(OS)显著相关,而FoxP3 +或PD-L1 +细胞的数量则不然。汇总CD8 + T细胞30μm范围内FoxP3 +或PD-L1 +细胞的数量,发现与靠近CD8 + T细胞的大量抑制性元件和缩短的OS存在显著关联。将该信息整合到累积抑制指数(CSI)中可增加与OS的相关性。将APM成分的肿瘤表达水平与CSI相结合可进一步提高预后能力。这种多参数免疫谱分析可能有助于对OSCC患者进行分层以开展临床试验。